Recently growing evidence has indicated that SGLT2i exhibits potential anti-tumor activity in specific types of cancer, which correlates with the presence or overexpression of SGLT2 on the surface of some specific cancer cells [29,30]. The gene discussed is SLC5A2; the disease is cancer.